OmniAb, Inc. Common Stock (OABI) Stock Price

OABIStock

$4.47+172.56%52W

Market Cap$649.90M

P/E—

PEG Ratio—

Div yield—

Beta0.65

OABI Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)146.45%

Price vs S&P 500 (4W)126.52%

VGM Score55.60

Book Value / Share (Quarterly)$1.81

P/TBV (Annual)1.88x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-31.89%

Cash Flow / Share (Quarterly)$-0.18

Price vs S&P 500 (YTD)128.80%

Gross Margin (TTM)98.91%

Net Profit Margin (TTM)-187.59%

EPS (TTM)$-0.46

10-Day Avg Trading Volume3.60M

EPS Excl Extra (TTM)$-0.46

Revenue Growth (5Y)-4.31%

EPS (Annual)$-0.57

ROI (Annual)-24.26%

Gross Margin (Annual)98.38%

Net Profit Margin (5Y Avg)-169.17%

Cash / Share (Quarterly)$0.34

Revenue Growth QoQ (YoY)247.30%

ROA (Last FY)-21.53%

Revenue Growth TTM (YoY)8.21%

EBITD / Share (TTM)$-0.35

ROE (5Y Avg)-16.00%

Operating Margin (TTM)-200.26%

Cash Flow / Share (Annual)$-0.26

P/B Ratio1.90x

P/B Ratio (Quarterly)0.87x

Net Income / Employee (Annual)$-727,900

EV / Revenue (TTM)16.23x

Net Interest Coverage (TTM)-3434.00x

ROA (TTM)-18.10%

EPS Incl Extra (Annual)$-0.57

Current Ratio (Annual)4.02x

Quick Ratio (Quarterly)4.58x

3-Month Avg Trading Volume1.04M

52-Week Price Return172.56%

Revenue / Employee (TTM)$325,200

Tangible BV / Share (Quarterly)$0.99

P/S Ratio (Annual)26.72x

Asset Turnover (Annual)0.06x

52-Week High$4.93

Operating Margin (5Y Avg)-200.51%

EPS Excl Extra (Annual)$-0.57

CapEx CAGR (5Y)-20.24%

26-Week Price Return158.38%

Quick Ratio (Annual)3.85x

13-Week Price Return64.34%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)4.80x

Enterprise Value$469.64M

Revenue / Share Growth (5Y)-4.06%

Asset Turnover (TTM)0.10x

Revenue / Employee (Annual)$209,700

Pretax Margin (Annual)-355.16%

Cash / Share (Annual)$0.37

3-Month Return Std Dev103.89%

Net Income / Employee (TTM)$-610,000

ROE (Last FY)-24.26%

EPS Basic Excl Extra (Annual)$-0.57

Receivables Turnover (TTM)3.03x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.46

Receivables Turnover (Annual)2.95x

ROI (TTM)-20.31%

P/S Ratio (TTM)17.23x

Pretax Margin (5Y Avg)-191.42%

Revenue / Share (Annual)$0.16

Tangible BV / Share (Annual)$0.98

Price vs S&P 500 (52W)154.00%

Year-to-Date Return141.62%

5-Day Price Return-5.10%

EPS Normalized (Annual)$-0.57

ROA (5Y Avg)-13.65%

Net Profit Margin (Annual)-347.04%

Month-to-Date Return125.76%

Cash Flow / Share (TTM)$-0.10

EBITD / Share (Annual)$-0.49

Operating Margin (Annual)-369.49%

ROI (5Y Avg)-16.00%

EPS Basic Excl Extra (TTM)$-0.46

P/TBV (Quarterly)1.58x

P/B Ratio (Annual)1.00x

Pretax Margin (TTM)-190.93%

Book Value / Share (Annual)$1.85

Price vs S&P 500 (13W)62.38%

Beta0.65x

P/FCF (Annual)709.37x

Revenue / Share (TTM)$0.23

ROE (TTM)-20.31%

52-Week Low$1.30

vGradeD

gGradeC

mGradeA

vgmGradeC

OABI Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 6, 2026	-$0.13	-$0.05	+60.78%(+$0.08)
Q1 2026	May 7, 2026	-$0.10	-$0.06	+37.93%(+$0.04)
Q4 2025	Mar 4, 2026	-$0.09	-$0.11	-25.71%(-$0.02)
Q3 2025	Nov 4, 2025	-$0.14	-$0.14	-2.94%(-$0.00)
Q2 2025	Aug 6, 2025	-$0.15	-$0.15	+1.10%(+$0.00)

OABI Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.23

Industry Peers — R&D — Physical Sciences(16)

Symbol	Value Score	Growth Score	Momentum Score	Price
OABIOmniAb, Inc. Common Stock	D	C	A	$4.47
IQVIQVIA Holdings Inc.	D	C	A	$261.75
INCYIncyte Genomics Inc	C	A	B	$124.37
MEDPMedpace Holdings, Inc. Common Stock	F	B	B	$600.65
CRLCharles River Laboratories International, Inc.	D	D	B	$291.50
ICLRIcon Plc	C	C	B	$170.02
ABSIAbsci Corporation Common Stock	F	F	A	$8.71
NRCNRC Health Common Stock	D	D	B	$21.85
MXCTMaxCyte, Inc. Common Stock	C	D	C	$1.22
IBACIB Acquisition Corp. Common Stock	—	D	C	$10.89
ONMDOneMedNet Corp Class A Common Stock	D	C	D	$0.58
ISPCiSpecimen Inc. Common Stock	D	F	F	$1.54
BIAFbioAffinity Technologies, Inc. Common Stock	A	F	F	$4.87
BIAFWbioAffinity Technologies, Inc. Warrant	—	—	F	$0.08
NOTVInotiv, Inc. Common Stock	A	B	F	$0.01
OABIWOmniAb, Inc. Warrant	—	—	A	$0.25
ONMDWOneMedNet Corp Warrant	—	—	D	$0.03

About OmniAb, Inc. Common Stock

OmniAb licenses antibody discovery technology to pharmaceutical and biotech companies and academic institutions. The platform uses engineered transgenic animals powered by proprietary Biological Intelligence to rapidly identify optimized antibody candidates for drug development. The company generates revenue through licensing agreements that accelerate its partners' therapeutic discovery efforts.